SharesGrow.com 標普和納斯達克內在價值聯繫我們

हिन्दी

← 返回所有股票

Landos Biopharma, Inc. LABP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Landos Biopharma, Inc. (LABP) 是一家生物科技公司，屬於醫療保健產業, 目前交易價格為 $22.93. 其SharesGrow評分為 39/100, 表明較弱的投資特徵， 7項中通過1項.

淨利潤為 $22M (虧損), 成長率為 +5.4%/yr. 淨利潤率為 0% (較薄). 毛利率為 98.9% (+0 pp 趨勢).

資產負債表: 總債務為 $0 對比 $32M 股東權益 (D/E比率 0, 保守). 流動比率為 6.09 (流動性強). 資產負債率為 0%. 總資產: $38M.

分析師展望: 2 / 7 位分析師評級 LABP 為買入 (29%) — 意見分歧.

SharesGrow 7項標準細分: Value ?/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 46/100 (Partial), Future 20/100 (Fail), Income ?/100 (Fail).

LABP SharesGrow 評分概覽

52/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

價值 0/100

估值 — P/E, PEG, Forward PEG

成長 40/100

財務數據 — 平均成長

過去 0/100

強勁 — 趨勢

健康 100/100

資產負債表 — D/E比率, 流動比率為

護城河 46/100

毛利率為 + market cap

未來 20/100

分析師展望 — 為買入

收入 0/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — LABP

No analyst coverage available for this stock.

LABP: -100%/yr 營收為, +5.4%/yr 淨利潤為平均成長. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

資產負債表 LABP: D/E比率 0 (保守), 流動比率為 6.09 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

護城河 Partial

LABP: 毛利率為 98.9% (+0 pp 趨勢), N/A market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 46/100. ≥ 70 = Pass.

View details →

分析師展望: 2 / 7 位分析師評級 LABP 為買入 (29%). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

View details →

No analyst coverage available for this stock.

Stock Chart & Stats

市場數據

52週區間3.145-22.94

成交量50.9K

30日平均成交量27.04K

市值$71.68M

Beta（1年）0.14

Share Statistics

EPS（TTM）-3.50

流通股數$6.28M

IPO Date2021-02-04

Employees19

CEOGregory Oakes

Financial Highlights & Ratios

EBITDA$-22.73M

Net Income$-21.94M

Operating Income$-22.73M

Total Cash$37.55M

Net Debt$-37.55M

Total Assets$38.04M

Price / Earnings (P/E)-6.6

Analyst Forecast

評級共識Hold

覆蓋分析師數7

買入 29% 持有 57% 賣出 14%

公司資訊

國家US

交易所NASDAQ Global Market

貨幣USD

ISINUS5150692011

股價走勢

LABP

Landos Biopharma, Inc. ↗ · NASDAQ Global Market

Healthcare • Biotechnology

3.15 52WK RANGE 22.94

其他人也在看

Angion Biomedica Corp.

Apollomics, Inc.

TransCode Therapeutics, Inc.

Xenetic Biosciences, Inc.

Cardio Diagnostics Holdings, Inc.

Navidea Biopharmaceuticals, Inc.

eFFECTOR Therapeutics, Inc.

聯繫我們

🎓

SharesGrow 學院

學習如何計算內在價值，發現被低估的股票。

每週線上課程

📧 [email protected]

📞 +65 8912 8000

給我們留言